Chang Hwan Pang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chang Hwan Pang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Jeong Eun Kim
Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
4 shared publicationsHyun-Seung Kang
Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
3 shared publications- Won-Sang Cho
Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
3 shared publications Chang Wan Oh
Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea
2 shared publicationsChi Heon Kim
Department of Neurosurgery, Seoul National University Hospital
2 shared publicationsChun Kee Chung
Department of Neurosurgery, Seoul National University Hospital
2 shared publications
Latest Publications
- 23 December 2023
- Published by Elsevier in World Neurosurgery
- Vol. 189, e1-e14
Angiographic and Clinical Outcomes of Various Techniques of Intracranial-to-Intracranial Bypass for Complex Cases with a Review of Pertinent Literature and Illustrated Cases
- 23 December 2023
- Published by Elsevier in World Neurosurgery
- Vol. 189, e1-e14
Angiographic and Clinical Outcomes of Various Techniques of Intracranial-to-Intracranial Bypass for Complex Cases with a Review of Pertinent Literature and Illustrated Cases
- 29 March 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (1) , 54-58
Is it safe to discontinue antiplatelet medication after stent-assisted coil embolization? If so, when is the best time?
- 29 March 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (1) , 54-58
Is it safe to discontinue antiplatelet medication after stent-assisted coil embolization? If so, when is the best time?
- 1 November 2021
- Published by Elsevier in World Neurosurgery
- Vol. 155, e529-e537
Endovascular Treatment of Intracranial Kissing Aneurysms: Technical Feasibility and Clinical Outcomes
- 1 November 2021
- Published by Elsevier in World Neurosurgery
- Vol. 155, e529-e537
Endovascular Treatment of Intracranial Kissing Aneurysms: Technical Feasibility and Clinical Outcomes
- 1 July 2021
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 206, 106719
Clinical application of 3D virtual and printed models for cerebrovascular diseases
- 1 July 2021
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 206, 106719
Clinical application of 3D virtual and printed models for cerebrovascular diseases
- Open Access
- 10 November 2019
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 62 (11) , 577-585
Diagnosis and treatment of adult Moyamoya disease
Moyamoya disease (MMD) refers to a chronic progressive steno-occlusive disease at the distal portion of the internal carotid artery with abnormal collateral vessel formation of unknown etiology. The definite diagnosis of MMD requires cerebral angiography or magnetic resonance angiography and/or magnetic resonance imaging after excluding other underlying diseases, particularly in adult patients. The treatment aims to improve regional cerebral blood flow to prevent cerebral ischemic events and alleviate hemodynamic instability that can provoke cerebral hemorrhage. Although various surgical revascularization methods have been introduced, combined revascularization surgery including direct revascularization is preferred over indirect revascularization only in adult MMD patients. Several recent studies have shown that surgical treatment has better outcomes and prognosis for symptomatic hemodynamically unstable MMD patients with both ischemic and hemorrhagic presentations. For asymptomatic patients, follow up with appropriate imaging is recommended. Surgery should be considered when new symptoms emerge with hemodynamic aggravation.
- 10 November 2019
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 62 (11) , 577-585
Open AccessDiagnosis and treatment of adult Moyamoya disease
Moyamoya disease (MMD) refers to a chronic progressive steno-occlusive disease at the distal portion of the internal carotid artery with abnormal collateral vessel formation of unknown etiology. The definite diagnosis of MMD requires cerebral angiography or magnetic resonance angiography and/or magnetic resonance imaging after excluding other underlying diseases, particularly in adult patients. The treatment aims to improve regional cerebral blood flow to prevent cerebral ischemic events and alleviate hemodynamic instability that can provoke cerebral hemorrhage. Although various surgical revascularization methods have been introduced, combined revascularization surgery including direct revascularization is preferred over indirect revascularization only in adult MMD patients. Several recent studies have shown that surgical treatment has better outcomes and prognosis for symptomatic hemodynamically unstable MMD patients with both ischemic and hemorrhagic presentations. For asymptomatic patients, follow up with appropriate imaging is recommended. Surgery should be considered when new symptoms emerge with hemodynamic aggravation.
- 1 July 2015
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 123 (1) , 65-74
Acute intracranial bleeding and recurrence after bur hole craniostomy for chronic subdural hematoma
OBJECT: There is inconsistency among the perioperative management strategies currently used for chronic subdural hematoma (cSDH). Moreover, postoperative complications such as acute intracranial bleeding and cSDH recurrence affect clinical outcome of cSDH surgery. This study evaluated the risk factors associated with acute intracranial bleeding and cSDH recurrence and identified an effective perioperative strategy for cSDH patients. METHODS: A retrospective study of patients who underwent bur hole craniostomy for cSDH between 2008 and 2012 was performed. RESULTS: A consecutive series of 303 cSDH patients (234 males and 69 females; mean age 67.17 years) was analyzed. Postoperative acute intracranial bleeding developed in 14 patients (4.57%) within a mean of 3.07 days and recurrence was observed in 37 patients (12.21%) within a mean of 31.69 days (range 10–104 days) after initial bur hole craniostomy. The comorbidities of hematological disease and prior shunt surgery were clinical factors associated with acute bleeding. There was a significant risk of recurrence in patients with diabetes mellitus, but recurrence did not affect the final neurological outcome (p = 0.776). Surgical details, including the number of operative bur holes, saline irrigation of the hematoma cavity, use of a drain, and type of postoperative ambulation, were not significantly associated with outcome. However, a large amount of drainage was associated with postoperative acute bleeding. CONCLUSIONS: Bur hole craniostomy is an effective surgical procedure for initial and recurrent cSDH. Patients with hematological disease or a history of prior shunt surgery are at risk for postoperative acute bleeding; therefore, these patients should be carefully monitored to avoid overdrainage. Surgeons should consider informing patients with diabetes mellitus that this comorbidity is associated with an increased likelihood of recurrence.
- 1 July 2015
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 123 (1) , 65-74
Acute intracranial bleeding and recurrence after bur hole craniostomy for chronic subdural hematoma
OBJECT: There is inconsistency among the perioperative management strategies currently used for chronic subdural hematoma (cSDH). Moreover, postoperative complications such as acute intracranial bleeding and cSDH recurrence affect clinical outcome of cSDH surgery. This study evaluated the risk factors associated with acute intracranial bleeding and cSDH recurrence and identified an effective perioperative strategy for cSDH patients. METHODS: A retrospective study of patients who underwent bur hole craniostomy for cSDH between 2008 and 2012 was performed. RESULTS: A consecutive series of 303 cSDH patients (234 males and 69 females; mean age 67.17 years) was analyzed. Postoperative acute intracranial bleeding developed in 14 patients (4.57%) within a mean of 3.07 days and recurrence was observed in 37 patients (12.21%) within a mean of 31.69 days (range 10–104 days) after initial bur hole craniostomy. The comorbidities of hematological disease and prior shunt surgery were clinical factors associated with acute bleeding. There was a significant risk of recurrence in patients with diabetes mellitus, but recurrence did not affect the final neurological outcome (p = 0.776). Surgical details, including the number of operative bur holes, saline irrigation of the hematoma cavity, use of a drain, and type of postoperative ambulation, were not significantly associated with outcome. However, a large amount of drainage was associated with postoperative acute bleeding. CONCLUSIONS: Bur hole craniostomy is an effective surgical procedure for initial and recurrent cSDH. Patients with hematological disease or a history of prior shunt surgery are at risk for postoperative acute bleeding; therefore, these patients should be carefully monitored to avoid overdrainage. Surgeons should consider informing patients with diabetes mellitus that this comorbidity is associated with an increased likelihood of recurrence.
- Open Access
- 1 January 2015
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 58 (3) , 262-270
Clinical Factors and Perioperative Strategies Associated with Outcome in Preinjury Antiplatelet and Anticoagulation Therapy for Patients with Traumatic Brain Injuries
Pang CH, et al. J Korean Neurosurg Soc. 2015 Sep;58(3):262-270. http://dx.doi.org/10.3340/jkns.2015.58.3.262
- 1 January 2015
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 58 (3) , 262-270
Open AccessClinical Factors and Perioperative Strategies Associated with Outcome in Preinjury Antiplatelet and Anticoagulation Therapy for Patients with Traumatic Brain Injuries
Pang CH, et al. J Korean Neurosurg Soc. 2015 Sep;58(3):262-270. http://dx.doi.org/10.3340/jkns.2015.58.3.262
- Open Access
- 1 January 2015
- Published by The Korean Spinal Neurosurgery Society in Korean Journal of Spine
- Vol. 12 (3) , 150-152
Intracranial Hypertension in a Patient with a Chiari Malformation Accompanied by Hyperthyroidism
The Chiari malformation is an infrequently detected congenital anomaly characterized by the downward displacement of the cerebellum with a tonsillar herniation below the foramen magnum that may be accompanied by either syringomyelia or hydrocephalus. Surgery, such as foramen magnum decompression, is indicated for a symptomatic Chiari malformation, although an incidental lesion may be followed-up without further treatment. Infrequently, increased intracranial pressure emerges due to hyperthyroidism. A nineteen-year-old girl visited our outpatient clinic presented with a headache, nausea and vomiting. A brain and spinal magnetic resonance image study (MRI) indicated that the patient had a Chiari I malformation without syringomyelia or hydrocephalus. An enlarged thyroid gland was detected on a physical examination, and serum markers indicated Graves' disease. The patient started anti-hyperthyroid medical treatment. Subsequently, the headache disappeared after the medical treatment of hyperthyroidism without surgical intervention for the Chiari malformation. A symptomatic Chiari malformation is indicated for surgery, but a surgeon should investigate other potential causes of the symptoms of the Chiari malformation to avoid unnecessary surgery.
- 1 January 2015
- Published by The Korean Spinal Neurosurgery Society in Korean Journal of Spine
- Vol. 12 (3) , 150-152
Open AccessIntracranial Hypertension in a Patient with a Chiari Malformation Accompanied by Hyperthyroidism
The Chiari malformation is an infrequently detected congenital anomaly characterized by the downward displacement of the cerebellum with a tonsillar herniation below the foramen magnum that may be accompanied by either syringomyelia or hydrocephalus. Surgery, such as foramen magnum decompression, is indicated for a symptomatic Chiari malformation, although an incidental lesion may be followed-up without further treatment. Infrequently, increased intracranial pressure emerges due to hyperthyroidism. A nineteen-year-old girl visited our outpatient clinic presented with a headache, nausea and vomiting. A brain and spinal magnetic resonance image study (MRI) indicated that the patient had a Chiari I malformation without syringomyelia or hydrocephalus. An enlarged thyroid gland was detected on a physical examination, and serum markers indicated Graves' disease. The patient started anti-hyperthyroid medical treatment. Subsequently, the headache disappeared after the medical treatment of hyperthyroidism without surgical intervention for the Chiari malformation. A symptomatic Chiari malformation is indicated for surgery, but a surgeon should investigate other potential causes of the symptoms of the Chiari malformation to avoid unnecessary surgery.